Oregon Bioscience Association Names New Board Officers and Directors

Business Wire, Feb 27, 2008

PORTLAND, Ore. -- Bill Newman returns as chairman of the Oregon Bioscience Association (OBA) Board of Directors for 2008. Newman is managing director with Northwest Technology Ventures. Other OBA board officers for 2008 are Carla Rathbun, secretary, consultant; Raymond Cheung, treasurer, Geffen Mesher & Co.; and Carol Pratt, legal counsel, K& L Gates.

Along with the officers, serving on the OBA Board of Directors for 2008 will be Doug Linquest, Welch Allyn; John Morgan, HemCon Medical Technologies; John Tortorici, Chart Solutions; Lew Nashner, Neurocom International, Inc.; Mary Erichsen, IBM Life Sciences; Phil Benz, Advanced Vascular Dynamics; Ann Bunnenberg, Electrical Geodesics, Inc.; Ann Demaree, Compview Medical; and Barry Starkman, Genentech. Also serving on the board are Blaine Metting, Pacific Northwest National Laboratory; Corey Schmid, Respironics; David Lyon, Bend Research, Inc.; Dianne Danowski Smith, The Ulum Group; Gordon Brown, Invitrogen; Greg Hahn, Synthetech Inc.; Jake Langer, Biotronik USA; Mark Haldeman, Evergreen Engineering; Nathan Gibson, Skanska USA; Jeff King, Virogenomics; Bob Monaghan, Oregon Translational Research and Drug Development Institute; Rich Linton, University of Oregon; Roger Weyel, AMES Technology; Sandy Shotwell, Alta Biomedical; Tim Stout, M.D., Oregon Health & Science University; Todd Hill, Precision Wire Components; and Ron Sherman, Silicon Valley Bank.

Alternates include Peter Murray, Welch Allyn; Arun Pradhan, Oregon Health & Science University; John Bial, Invitrogen; Juergen Lindner, Biotronik USA; Keith Martin, Precision Wire Components; Tina Kellogg, Bend Research Inc.; and Todd Kaufman, Genentech.

About the Oregon Bioscience Association

The Oregon Bioscience Association promotes the growth and quality of the bioscience industry in Oregon. OBA continually seeks ways to support sustainability and growth in the life science, bioscience, biotechnology and device manufacturing industries and to create acceleration initiatives so members can achieve their full scientific, economic and social potential. OBA, a nonprofit membership association, is the Oregon affiliate of the Biotechnology Industry Organization.

Oregon has 230 private bioscience companies and 13 life science research institutions generating $2.5 billion in annual revenues and employing more than 9,000 employees in the private sector and 2,000 in the research sector. Oregon's bioscience industry contributes more than $2.5 billion to the state's economy.